Harmon Seth
Viridian Therapeutics, Inc. · Chief Financial Officer
Harmon Seth is listed in public filings as officer: Chief Financial Officer. This Harmon Seth insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Viridian Therapeutics, Inc. (VRDN). Investors use Harmon Seth's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --9.9k shares | Grant / ExerciseMar 3, 2026 | Disclosure amount unavailable6.3k shares | -- | -- | |
| $237k7.9k shares | Grant / ExerciseMar 3, 2026 | $61.3K2k shares | $30.19 | -- | |
| $228k7.8k shares | Grant / ExerciseMar 3, 2026 | $61.3K2.1k shares | $29.32 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $3.1M102.9k shares | Grant / ExerciseMar 2, 2026 | $3.1M102.9k shares | $30.25 | -- | |
| --20.6k shares | Grant / ExerciseMar 2, 2026 | Disclosure amount unavailable20.6k shares | -- | -- | |
| $2.2M150.4k shares | Grant / ExerciseMar 3, 2025 | $2.2M150.4k shares | $14.41 | -- | |
| --25.1k shares | Grant / ExerciseMar 3, 2025 | Disclosure amount unavailable25.1k shares | -- | -- |